EE65 Evaluating the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Strategy in Oncology and Implications for Policy: A Literature Review
Abstract
Authors
T. Wilsdon M. Mirza L. Goerke
T. Wilsdon M. Mirza L. Goerke
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now